According to Sellas Life Sciences's latest financial reports the company's current earnings (TTM) are -$37.87 M. an increase over its 2022 earnings that were of -$41.95 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$37.87 M | -9.73% |
2022 | -$41.95 M | 65.85% |
2021 | -$25.3 M | 48.95% |
2020 | -$16.99 M | -1.31% |
2019 | -$17.21 M | -44.65% |
2018 | -$31.09 M | 45.99% |
2017 | -$21.3 M | -33.17% |
2016 | -$31.87 M | -6.87% |
2015 | -$34.22 M | -30.98% |
2014 | -$49.59 M | 46.52% |
2013 | -$33.84 M | |
2011 | -$16.8 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 192.53% | ๐บ๐ธ USA |